Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma.

Lawrie CH, Chi J, Taylor S, Tramonti D, Ballabio E, Palazzo S, Saunders NJ, Pezzella F, Boultwood J, Wainscoat JS, Hatton CS.

J Cell Mol Med. 2009 Jul;13(7):1248-60. doi: 10.1111/j.1582-4934.2008.00628.x. Epub 2008 Dec 24.

2.

miR-31 and miR-17-5p levels change during transformation of follicular lymphoma.

Thompson MA, Edmonds MD, Liang S, McClintock-Treep S, Wang X, Li S, Eischen CM.

Hum Pathol. 2016 Apr;50:118-26. doi: 10.1016/j.humpath.2015.11.011. Epub 2015 Nov 30.

3.

A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines.

Culpin RE, Proctor SJ, Angus B, Crosier S, Anderson JJ, Mainou-Fowler T.

Int J Oncol. 2010 Aug;37(2):367-76.

PMID:
20596664
5.

Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations.

Martinez-Climent JA, Alizadeh AA, Segraves R, Blesa D, Rubio-Moscardo F, Albertson DG, Garcia-Conde J, Dyer MJ, Levy R, Pinkel D, Lossos IS.

Blood. 2003 Apr 15;101(8):3109-17. Epub 2002 Oct 24.

6.

MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma.

Lawrie CH, Soneji S, Marafioti T, Cooper CD, Palazzo S, Paterson JC, Cattan H, Enver T, Mager R, Boultwood J, Wainscoat JS, Hatton CS.

Int J Cancer. 2007 Sep 1;121(5):1156-61.

7.

Genomic imbalances during transformation from follicular lymphoma to diffuse large B-cell lymphoma.

Berglund M, Enblad G, Thunberg U, Amini RM, Sundström C, Roos G, Erlanson M, Rosenquist R, Larsson C, Lagercrantz S.

Mod Pathol. 2007 Jan;20(1):63-75. Epub 2006 Sep 29.

8.

MicroRNA profiling of primary cutaneous large B-cell lymphomas.

Koens L, Qin Y, Leung WY, Corver WE, Jansen PM, Willemze R, Vermeer MH, Tensen CP.

PLoS One. 2013 Dec 16;8(12):e82471. doi: 10.1371/journal.pone.0082471. eCollection 2013.

9.

Diffuse large B cell lymphoma derived from nodular lymphocyte predominant Hodgkin lymphoma presents with variable histopathology.

Hartmann S, Eray M, Döring C, Lehtinen T, Brunnberg U, Kujala P, Vornanen M, Hansmann ML.

BMC Cancer. 2014 May 13;14:332. doi: 10.1186/1471-2407-14-332.

10.

Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes.

Lossos IS, Alizadeh AA, Diehn M, Warnke R, Thorstenson Y, Oefner PJ, Brown PO, Botstein D, Levy R.

Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8886-91. Epub 2002 Jun 19.

12.
13.

The miR-17-92 microRNA cluster: a novel diagnostic tool in large B-cell malignancies.

Fassina A, Marino F, Siri M, Zambello R, Ventura L, Fassan M, Simonato F, Cappellesso R.

Lab Invest. 2012 Nov;92(11):1574-82. doi: 10.1038/labinvest.2012.129. Epub 2012 Sep 10.

14.

BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab.

Iqbal J, Meyer PN, Smith LM, Johnson NA, Vose JM, Greiner TC, Connors JM, Staudt LM, Rimsza L, Jaffe E, Rosenwald A, Ott G, Delabie J, Campo E, Braziel RM, Cook JR, Tubbs RR, Gascoyne RD, Armitage JO, Weisenburger DD, Chan WC.

Clin Cancer Res. 2011 Dec 15;17(24):7785-95. doi: 10.1158/1078-0432.CCR-11-0267. Epub 2011 Sep 20.

15.

Clonal heterogeneity assessed by flow cytometry in B-cell lymphomas arising from germinal centers.

Bellido M, Rubiol E, Ubeda J, Estivill C, Perea G, Rego-Araujo J, Aventín A, Bordes R, Sierra J, Nomdedéu JF.

Am J Clin Pathol. 2002 Jun;117(6):864-70.

PMID:
12047137
16.

Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.

Ghesquières H, Berger F, Felman P, Callet-Bauchu E, Bryon PA, Traverse-Glehen A, Thieblemont C, Baseggio L, Michallet AS, Coiffier B, Salles G.

J Clin Oncol. 2006 Nov 20;24(33):5234-41. Epub 2006 Oct 16.

PMID:
17043351
17.

Gene expression profile of serial samples of transformed B-cell lymphomas.

de Vos S, Hofmann WK, Grogan TM, Krug U, Schrage M, Miller TP, Braun JG, Wachsman W, Koeffler HP, Said JW.

Lab Invest. 2003 Feb;83(2):271-85.

PMID:
12594241
18.

Follicle center lymphoma is associated with significantly elevated levels of BCL-6 expression among lymphoma subtypes, independent of chromosome 3q27 rearrangements.

Jardin F, Buchonnet G, Parmentier F, Contentin N, Leprêtre S, Lenain P, Picquenot JM, Laberge S, Bertrand P, Stamatoullas A, D'Anjou J, Tilly H, Bastard C.

Leukemia. 2002 Nov;16(11):2318-25.

19.

B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.

Snuderl M, Kolman OK, Chen YB, Hsu JJ, Ackerman AM, Dal Cin P, Ferry JA, Harris NL, Hasserjian RP, Zukerberg LR, Abramson JS, Hochberg EP, Lee H, Lee AI, Toomey CE, Sohani AR.

Am J Surg Pathol. 2010 Mar;34(3):327-40. doi: 10.1097/PAS.0b013e3181cd3aeb.

20.

MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas.

Roehle A, Hoefig KP, Repsilber D, Thorns C, Ziepert M, Wesche KO, Thiere M, Loeffler M, Klapper W, Pfreundschuh M, Matolcsy A, Bernd HW, Reiniger L, Merz H, Feller AC.

Br J Haematol. 2008 Sep;142(5):732-44. doi: 10.1111/j.1365-2141.2008.07237.x. Epub 2008 Jun 3.

PMID:
18537969

Supplemental Content

Support Center